The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets - Archive ouverte HAL Access content directly
Journal Articles British Journal of Pharmacology Year : 2021

The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets

(1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 2)
1
2

Abstract

Metabolic pathways have emerged as cornerstones in carcinogenic deregulation providing new therapeutic strategies for cancer management. Recently, a new branch of cholesterol metabolism has been discovered involving the biochemical transformation of 5,6-epoxycholesterols (5,6-ECs). The 5,6-ECs are metabolized in breast cancers to the tumour promoter oncosterone whereas, in normal breast tissue, they are metabolized to the tumour suppressor metabolite, dendrogenin A (DDA). Blocking the mitogenic and invasive potential of oncosterone will present new opportunities for breast cancer treatment. The reactivation of DDA biosynthesis, or its use as a drug, represents promising therapeutic approaches such as DDA-deficiency complementation, activation of breast cancer cell re-differentiation and breast cancer chemoprevention. This review presents current knowledge of the 5,6-EC metabolic pathway in breast cancer, focusing on the 5,6-EC metabolic enzymes ChEH and HSD11B2 and on 5,6-EC metabolite targets, the oxysterol receptor (LXRβ) and the glucocorticoid receptor. LINKED ARTICLES: This article is part of a themed issue on Oxysterols, Lifelong Health and Therapeutics. To view the other articles in this section visit
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03394464 , version 1 (22-10-2021)

Identifiers

Cite

Philippe Medina, Khadijetou Diallo, Emilie Huc‐claustre, Mehdi Attia, Régis Soulès, et al.. The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets. British Journal of Pharmacology, 2021, 178 (16), pp.3248-3260. ⟨10.1111/bph.15205⟩. ⟨inserm-03394464⟩
16 View
17 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More